Re: Chart of ALNY and MDCO
I think it is a combination of several factors driving ALNY down. High cash burn, fear of competition from Pfizer and about 10 million new shares entering the market from SNY. ALNY is also now a commercial company and it is valued differently. It is now valued more on multiple of sales so it can remain depressed for quite some time unless its revenue shoots up rapidly. I thought of selling some of my ALNY and buying MDCO when MDCO was around 18. But I thought MDCO was too risky being a single drug company. I regret my decision now. Now is a long wait for ALNY to come back. But analysts keep on raising their price target on ALNY and I hope they are correct.